| positive regulation of transforming growth factor beta secretion | GO:2001203 | 1 | 0.254 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.136 | |
| regulation of transforming growth factor beta secretion | GO:2001201 | 1 | 0.128 | |
| transforming growth factor beta secretion | GO:0038044 | 1 | 0.128 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.124 | |
| regulation of protein localization | GO:0032880 | 231 | 0.089 | |
| limb development | GO:0060173 | 166 | 0.085 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.081 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.079 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.068 | |
| regulation of protein transport | GO:0051223 | 163 | 0.066 | |
| protein processing | GO:0016485 | 163 | 0.064 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.061 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.059 | |
| stem cell development | GO:0048864 | 219 | 0.058 | |
| amine metabolic process | GO:0009308 | 45 | 0.058 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.057 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.056 | |
| cell adhesion | GO:0007155 | 329 | 0.056 | |
| muscle tissue development | GO:0060537 | 308 | 0.055 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.054 | |
| skeletal system development | GO:0001501 | 356 | 0.054 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.050 | |
| immune effector process | GO:0002252 | 321 | 0.049 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.048 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.046 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.046 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.044 | |
| carnitine transmembrane transport | GO:1902603 | 3 | 0.044 | |
| digestive tract development | GO:0048565 | 190 | 0.044 | |
| regulation of interleukin 10 secretion | GO:2001179 | 4 | 0.044 | |
| neuron migration | GO:0001764 | 122 | 0.044 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.043 | |
| cellular response to lipid | GO:0071396 | 145 | 0.042 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.042 | |
| sensory perception | GO:0007600 | 245 | 0.041 | |
| stem cell differentiation | GO:0048863 | 268 | 0.041 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.040 | |
| spermatogenesis | GO:0007283 | 284 | 0.039 | |
| male gamete generation | GO:0048232 | 285 | 0.039 | |
| interleukin 10 secretion | GO:0072608 | 4 | 0.038 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.038 | |
| placenta development | GO:0001890 | 140 | 0.038 | |
| anion transport | GO:0006820 | 177 | 0.037 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.037 | |
| positive regulation of reactive oxygen species biosynthetic process | GO:1903428 | 2 | 0.037 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.036 | |
| protein secretion | GO:0009306 | 111 | 0.036 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.036 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.035 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.035 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.034 | |
| kidney development | GO:0001822 | 213 | 0.034 | |
| regulation of cell motility | GO:2000145 | 236 | 0.034 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.034 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.034 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.034 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.034 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.033 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.033 | |
| epidermis development | GO:0008544 | 187 | 0.033 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.033 | |
| inflammatory response | GO:0006954 | 244 | 0.033 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.033 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.032 | |
| embryonic placenta development | GO:0001892 | 98 | 0.032 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.032 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.032 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.032 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.032 | |
| protein catabolic process | GO:0030163 | 221 | 0.032 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.032 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.031 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.031 | |
| regulation of secretion | GO:0051046 | 274 | 0.031 | |
| amino acid transmembrane transport | GO:0003333 | 37 | 0.031 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.031 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.031 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.031 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.030 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.030 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.030 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.030 | |
| limb morphogenesis | GO:0035108 | 149 | 0.030 | |
| membrane organization | GO:0061024 | 245 | 0.030 | |
| mapk cascade | GO:0000165 | 281 | 0.030 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.030 | |
| protein maturation | GO:0051604 | 176 | 0.030 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.029 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.029 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.029 | |
| gliogenesis | GO:0042063 | 141 | 0.029 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.029 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.029 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.028 | |
| regulation of ossification | GO:0030278 | 112 | 0.028 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.028 | |
| regulation of cell activation | GO:0050865 | 289 | 0.028 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.028 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.028 | |
| steroid metabolic process | GO:0008202 | 119 | 0.028 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.028 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.028 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.028 | |
| angiogenesis | GO:0001525 | 201 | 0.028 | |
| axonogenesis | GO:0007409 | 274 | 0.027 | |
| rhombomere 5 development | GO:0021571 | 4 | 0.027 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.027 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.027 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.027 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.027 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.026 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.026 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.026 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.026 | |
| positive regulation of cytokine secretion | GO:0050715 | 41 | 0.026 | |
| oxidation reduction process | GO:0055114 | 342 | 0.026 | |
| cellular homeostasis | GO:0019725 | 240 | 0.026 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.026 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.026 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.026 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.025 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.025 | |
| carnitine transport | GO:0015879 | 3 | 0.025 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.025 | |
| chemotaxis | GO:0006935 | 247 | 0.025 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.025 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.025 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.025 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.025 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.025 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.025 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.024 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.024 | |
| ossification | GO:0001503 | 216 | 0.024 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.024 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.024 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.024 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.024 | |
| gland development | GO:0048732 | 330 | 0.024 | |
| carbon catabolite repression of transcription from rna polymerase ii promoter | GO:0000437 | 1 | 0.024 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.024 | |
| forebrain development | GO:0030900 | 302 | 0.024 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.024 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.024 | |
| mesonephric epithelium development | GO:0072163 | 94 | 0.023 | |
| response to growth factor | GO:0070848 | 198 | 0.023 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.023 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.023 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.023 | |
| wound healing | GO:0042060 | 157 | 0.023 | |
| cytokine production | GO:0001816 | 319 | 0.023 | |
| negative regulation of growth | GO:0045926 | 99 | 0.023 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.023 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.022 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.022 | |
| response to acid chemical | GO:0001101 | 111 | 0.022 | |
| skin development | GO:0043588 | 220 | 0.022 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.022 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.022 | |
| cell maturation | GO:0048469 | 127 | 0.022 | |
| tube formation | GO:0035148 | 140 | 0.022 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.022 | |
| amino acid betaine transport | GO:0015838 | 3 | 0.022 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.022 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.022 | |
| circulatory system process | GO:0003013 | 197 | 0.022 | |
| intermediate filament cytoskeleton organization | GO:0045104 | 26 | 0.022 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.021 | |
| trachea cartilage morphogenesis | GO:0060535 | 4 | 0.021 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.021 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.021 | |
| mitotic chromosome condensation | GO:0007076 | 1 | 0.021 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.021 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.021 | |
| hormone metabolic process | GO:0042445 | 86 | 0.021 | |
| regulation of system process | GO:0044057 | 200 | 0.021 | |
| regulation of phospholipase c activity | GO:1900274 | 3 | 0.021 | |
| negative regulation of b cell activation | GO:0050869 | 27 | 0.021 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.021 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.021 | |
| muscle contraction | GO:0006936 | 101 | 0.021 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.021 | |
| kidney epithelium development | GO:0072073 | 121 | 0.021 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.021 | |
| c21 steroid hormone biosynthetic process | GO:0006700 | 3 | 0.021 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.021 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.020 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.020 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.020 | |
| renal system development | GO:0072001 | 225 | 0.020 | |
| erk1 and erk2 cascade | GO:0070371 | 77 | 0.020 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.020 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.020 | |
| connective tissue development | GO:0061448 | 179 | 0.020 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.020 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.020 | |
| renal tubule development | GO:0061326 | 87 | 0.020 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.020 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.020 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.020 | |
| progesterone metabolic process | GO:0042448 | 4 | 0.020 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.020 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.019 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.019 | |
| nuclear division | GO:0000280 | 158 | 0.019 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.019 | |
| defense response to other organism | GO:0098542 | 197 | 0.019 | |
| aspartate family amino acid metabolic process | GO:0009066 | 10 | 0.019 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.019 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.019 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.019 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.019 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.019 | |
| glial cell differentiation | GO:0010001 | 131 | 0.019 | |
| learning or memory | GO:0007611 | 148 | 0.019 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.019 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.019 | |
| oocyte axis specification | GO:0007309 | 2 | 0.019 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.019 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.019 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.019 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.019 | |
| av node cell to bundle of his cell communication | GO:0086067 | 2 | 0.019 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.019 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.019 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.018 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.018 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.018 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.018 | |
| endomembrane system organization | GO:0010256 | 147 | 0.018 | |
| intestinal epithelial cell maturation | GO:0060574 | 2 | 0.018 | |
| oocyte construction | GO:0007308 | 2 | 0.018 | |
| regulation of toll like receptor 4 signaling pathway | GO:0034143 | 4 | 0.018 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.018 | |
| mesonephros development | GO:0001823 | 97 | 0.018 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.018 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.018 | |
| heart contraction | GO:0060047 | 93 | 0.018 | |
| urogenital system development | GO:0001655 | 261 | 0.018 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.018 | |
| nephron development | GO:0072006 | 109 | 0.018 | |
| organic acid transport | GO:0015849 | 101 | 0.018 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.018 | |
| regulation of satellite cell activation involved in skeletal muscle regeneration | GO:0014717 | 3 | 0.018 | |
| respiratory tube development | GO:0030323 | 167 | 0.018 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.018 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.018 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.018 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.018 | |
| tissue homeostasis | GO:0001894 | 115 | 0.018 | |
| segmentation | GO:0035282 | 93 | 0.018 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.018 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.017 | |
| response to inorganic substance | GO:0010035 | 96 | 0.017 | |
| peptide metabolic process | GO:0006518 | 46 | 0.017 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.017 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.017 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.017 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.017 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.017 | |
| neuron projection guidance | GO:0097485 | 141 | 0.017 | |
| response to nutrient levels | GO:0031667 | 109 | 0.017 | |
| translation | GO:0006412 | 93 | 0.017 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.017 | |
| response to molecule of fungal origin | GO:0002238 | 4 | 0.017 | |
| feeding behavior | GO:0007631 | 62 | 0.017 | |
| response to peptide | GO:1901652 | 136 | 0.017 | |
| positive regulation of protein secretion | GO:0050714 | 52 | 0.017 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 82 | 0.017 | |
| small molecule catabolic process | GO:0044282 | 71 | 0.017 | |
| regulation of defense response | GO:0031347 | 233 | 0.016 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.016 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.016 | |
| organic anion transport | GO:0015711 | 137 | 0.016 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.016 | |
| intermediate filament based process | GO:0045103 | 27 | 0.016 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.016 | |
| anion transmembrane transport | GO:0098656 | 71 | 0.016 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.016 | |
| blastocyst development | GO:0001824 | 80 | 0.016 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.016 | |
| cation homeostasis | GO:0055080 | 212 | 0.016 | |
| stem cell proliferation | GO:0072089 | 117 | 0.016 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.016 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.016 | |
| muscle system process | GO:0003012 | 141 | 0.016 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.016 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.016 | |
| response to peptide hormone | GO:0043434 | 127 | 0.016 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.016 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.016 | |
| positive regulation of phospholipase activity | GO:0010518 | 3 | 0.016 | |
| regulation of translation | GO:0006417 | 71 | 0.016 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.016 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.016 | |
| regulation of protein localization to nucleus | GO:1900180 | 60 | 0.016 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.016 | |
| pallium development | GO:0021543 | 120 | 0.016 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.016 | |
| bone development | GO:0060348 | 120 | 0.016 | |
| telencephalon cell migration | GO:0022029 | 55 | 0.015 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.015 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.015 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.015 | |
| regulation of protein processing | GO:0070613 | 96 | 0.015 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.015 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.015 | |
| cognition | GO:0050890 | 149 | 0.015 | |
| androgen biosynthetic process | GO:0006702 | 4 | 0.015 | |
| cytokine secretion | GO:0050663 | 72 | 0.015 | |
| cardiac chamber development | GO:0003205 | 108 | 0.015 | |
| endocytosis | GO:0006897 | 168 | 0.015 | |
| stem cell maintenance | GO:0019827 | 130 | 0.015 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.015 | |
| gonad development | GO:0008406 | 141 | 0.015 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.015 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.015 | |
| negative regulation of fat cell proliferation | GO:0070345 | 2 | 0.015 | |
| hindbrain development | GO:0030902 | 128 | 0.015 | |
| granulosa cell differentiation | GO:0060014 | 1 | 0.015 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.015 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.015 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.015 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.015 | |
| appendage development | GO:0048736 | 166 | 0.015 | |
| cell cell adhesion | GO:0098609 | 41 | 0.015 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.015 | |
| t cell activation | GO:0042110 | 289 | 0.015 | |
| midgut development | GO:0007494 | 4 | 0.014 | |
| positive regulation of protein localization to nucleus | GO:1900182 | 30 | 0.014 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.014 | |
| cation transport | GO:0006812 | 399 | 0.014 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.014 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.014 | |
| regulation of cell migration | GO:0030334 | 219 | 0.014 | |
| locomotory behavior | GO:0007626 | 195 | 0.014 | |
| amino acid transport | GO:0006865 | 61 | 0.014 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.014 | |
| sperm motility | GO:0030317 | 47 | 0.014 | |
| lipid localization | GO:0010876 | 126 | 0.014 | |
| single fertilization | GO:0007338 | 82 | 0.014 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.014 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.014 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.014 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.014 | |
| phagocytosis | GO:0006909 | 66 | 0.014 | |
| ear development | GO:0043583 | 200 | 0.014 | |
| satellite cell activation involved in skeletal muscle regeneration | GO:0014901 | 3 | 0.014 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.014 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.014 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.014 | |
| ureteric bud development | GO:0001657 | 94 | 0.014 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.014 | |
| innate immune response | GO:0045087 | 157 | 0.014 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.014 | |
| respiratory system development | GO:0060541 | 190 | 0.014 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.014 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.014 | |
| monocarboxylic acid transport | GO:0015718 | 44 | 0.014 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.014 | |
| peptide transport | GO:0015833 | 133 | 0.014 | |
| telencephalon development | GO:0021537 | 186 | 0.014 | |
| male sex differentiation | GO:0046661 | 109 | 0.014 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.014 | |
| cell cell signaling involved in mammary gland development | GO:0060764 | 2 | 0.014 | |
| cellular response to peptide | GO:1901653 | 92 | 0.014 | |
| developmental maturation | GO:0021700 | 193 | 0.014 | |
| fertilization | GO:0009566 | 127 | 0.014 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.014 | |
| somite development | GO:0061053 | 81 | 0.014 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.014 | |
| lipid modification | GO:0030258 | 65 | 0.014 | |
| blood circulation | GO:0008015 | 195 | 0.014 | |
| regulation of wound healing | GO:0061041 | 40 | 0.014 | |
| female gonad development | GO:0008585 | 71 | 0.014 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.014 | |
| single organism nuclear import | GO:1902593 | 95 | 0.014 | |
| fat cell differentiation | GO:0045444 | 160 | 0.013 | |
| transmembrane transport | GO:0055085 | 412 | 0.013 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.013 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.013 | |
| response to oxidative stress | GO:0006979 | 123 | 0.013 | |
| myeloid leukocyte mediated immunity | GO:0002444 | 42 | 0.013 | |
| response to drug | GO:0042493 | 75 | 0.013 | |
| positive regulation of nucleocytoplasmic transport | GO:0046824 | 30 | 0.013 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.013 | |
| cell differentiation involved in embryonic placenta development | GO:0060706 | 26 | 0.013 | |
| negative regulation of wnt signaling pathway involved in heart development | GO:0003308 | 4 | 0.013 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.013 | |
| nuclear transport | GO:0051169 | 139 | 0.013 | |
| adaptive immune response | GO:0002250 | 155 | 0.013 | |
| maintenance of location | GO:0051235 | 89 | 0.013 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.013 | |
| regulation of erk1 and erk2 cascade | GO:0070372 | 71 | 0.013 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.013 | |
| germ cell development | GO:0007281 | 185 | 0.013 | |
| neuron projection extension | GO:1990138 | 64 | 0.013 | |
| cellular amide metabolic process | GO:0043603 | 58 | 0.013 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.013 | |
| digestive system development | GO:0055123 | 200 | 0.013 | |
| dna metabolic process | GO:0006259 | 303 | 0.013 | |
| eye photoreceptor cell development | GO:0042462 | 31 | 0.013 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.013 | |
| negative regulation of leukocyte proliferation | GO:0070664 | 46 | 0.013 | |
| protein localization to organelle | GO:0033365 | 185 | 0.013 | |
| negative regulation of lymphocyte activation | GO:0051250 | 91 | 0.013 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.013 | |
| female sex differentiation | GO:0046660 | 84 | 0.013 | |
| organelle fission | GO:0048285 | 170 | 0.013 | |
| b cell activation | GO:0042113 | 161 | 0.013 | |
| extracellular structure organization | GO:0043062 | 148 | 0.013 | |
| response to amino acid | GO:0043200 | 37 | 0.013 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 85 | 0.013 | |
| planar cell polarity pathway involved in outflow tract morphogenesis | GO:0061347 | 2 | 0.013 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.013 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.013 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.013 | |
| positive regulation of ras gtpase activity | GO:0032320 | 65 | 0.013 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.013 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.012 | |
| camera type eye development | GO:0043010 | 266 | 0.012 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.012 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.012 | |
| multicellular organismal water homeostasis | GO:0050891 | 23 | 0.012 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.012 | |
| mitral valve morphogenesis | GO:0003183 | 4 | 0.012 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.012 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.012 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.012 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.012 | |
| exocytosis | GO:0006887 | 121 | 0.012 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.012 | |
| regulation of cardiac chamber morphogenesis | GO:1901219 | 2 | 0.012 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.012 | |
| regionalization | GO:0003002 | 337 | 0.012 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.012 | |
| biomineral tissue development | GO:0031214 | 64 | 0.012 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.012 | |
| adult behavior | GO:0030534 | 135 | 0.012 | |
| regulation of leukocyte apoptotic process | GO:2000106 | 56 | 0.012 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.012 | |
| l amino acid transport | GO:0015807 | 32 | 0.012 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.012 | |
| neural tube development | GO:0021915 | 160 | 0.012 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.012 | |
| cell division | GO:0051301 | 120 | 0.012 | |
| alpha amino acid metabolic process | GO:1901605 | 59 | 0.012 | |
| response to steroid hormone | GO:0048545 | 56 | 0.012 | |
| wound healing involved in inflammatory response | GO:0002246 | 4 | 0.012 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.012 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.012 | |
| defense response to bacterium | GO:0042742 | 119 | 0.012 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.012 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.012 | |
| dephosphorylation | GO:0016311 | 129 | 0.012 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.012 | |
| epithelial cell morphogenesis | GO:0003382 | 41 | 0.012 | |
| interleukin 8 secretion | GO:0072606 | 3 | 0.012 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.012 | |
| cellular alcohol metabolic process | GO:0044107 | 3 | 0.012 | |
| somitogenesis | GO:0001756 | 69 | 0.012 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.012 | |
| positive regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043280 | 36 | 0.012 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.012 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.012 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.012 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.012 | |
| hormone secretion | GO:0046879 | 128 | 0.012 | |
| plasma membrane organization | GO:0007009 | 90 | 0.012 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.012 | |
| immune response regulating cell surface receptor signaling pathway | GO:0002768 | 80 | 0.012 | |
| positive regulation of vasoconstriction | GO:0045907 | 4 | 0.012 | |
| sensory perception of light stimulus | GO:0050953 | 54 | 0.012 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.012 | |
| regulation of systemic arterial blood pressure mediated by a chemical signal | GO:0003044 | 33 | 0.012 | |
| proteasomal protein catabolic process | GO:0010498 | 98 | 0.012 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.012 | |
| regulation of interleukin 8 secretion | GO:2000482 | 2 | 0.012 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.012 | |
| regulation of fat cell proliferation | GO:0070344 | 4 | 0.011 | |
| regulation of toll like receptor 2 signaling pathway | GO:0034135 | 3 | 0.011 | |
| spermatid development | GO:0007286 | 108 | 0.011 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.011 | |
| male gonad development | GO:0008584 | 88 | 0.011 | |
| endochondral bone morphogenesis | GO:0060350 | 50 | 0.011 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.011 | |
| neural tube formation | GO:0001841 | 108 | 0.011 | |
| cell growth | GO:0016049 | 130 | 0.011 | |
| negative regulation of map kinase activity | GO:0043407 | 34 | 0.011 | |
